screenshot of video for Dr. Sui Huang on the Science Behind Masks

Dr. Sui Huang on the Science Behind Masks

On April 7, 2022, Dr. Sui Huang spoke at a Research Roundtable event on the topic of "The Science Behind Masks." In light of the recent changes to masking mandates, Dr. Huang explained the science behind how masks work and gave the tools to make an informed decision for yourself.

Dr. Sui Huang on the Science Behind Masks
Dr. Sui Huang on the Science Behind Masks
recover - researching covid graphic

Understanding, Preventing and Treating Long-Term Effects of COVID: RECOVER Study Enrolling Patients from Pacific Northwest

As part of a massive nationwide effort, ISB is leading a multi-site consortium for the NIH RECOVER (Researching COVID to Enhance Recovery) Initiative. The Pacific Northwest consortium is made up of ISB, Providence, Swedish, and University of Washington School of Medicine.

Understanding, Preventing and Treating Long-Term Effects of COVID: RECOVER Study Enrolling Patients from Pacific Northwest
Understanding, Preventing and Treating Long-Term Effects of COVID: RECOVER Study Enrolling Patients from Pacific Northwest
screenshot of video for Predicting ‘Long COVID’ At Initial Point of COVID-19 Diagnosis

Predicting ‘Long COVID’ At Initial Point of COVID-19 Diagnosis

Researchers have identified several factors that can be measured at the initial point of COVID-19 diagnosis that anticipate if a patient is likely to develop long COVID. They also found that mild cases of COVID-19, not just severe cases, are associated with long COVID. Their findings were published by the journal Cell.

Predicting ‘Long COVID’ At Initial Point of COVID-19 Diagnosis
Predicting ‘Long COVID’ At Initial Point of COVID-19 Diagnosis
screenshot of video for Research Roundtable with Dr. Jim Heath on COVID

Research Roundtable with Dr. Jim Heath on COVID

On January 18, 2022, Dr. Jim Heath gave a talk on COVID at the first Research Roundtable event of 2022. Research Roundtable is a series of ISB hosted conversations with our leading scientists on the latest research happening at ISB. Designed for a lay audience, this series is open to all. Attendees have the opportunity to ask questions directly to our scientists.

Research Roundtable with Dr. Jim Heath on COVID
Research Roundtable with Dr. Jim Heath on COVID
screenshot of video for Maternal COVID-19 Infection Increases Risks of Preterm Birth, Low Birth Weight and Stillbirth

Maternal COVID-19 Infection Increases Risks of Preterm Birth, Low Birth Weight and Stillbirth

An ISB-led study examined the electronic health records of more than 18,000 people with SARS-CoV-2 tests during pregnancy, and found that those who contracted COVID-19 while pregnant were more likely to have poor birth outcomes including preterm birth, small for gestational age, low birth weight, and stillbirth. 

Maternal COVID-19 Infection Increases Risks of Preterm Birth, Low Birth Weight and Stillbirth
Maternal COVID-19 Infection Increases Risks of Preterm Birth, Low Birth Weight and Stillbirth
Baliga Postdoctoral Fellow Training

ISB Creates Algorithms To Accelerate Discovery of Efficacious Treatments for Tuberculosis

Tuberculosis (TB) is the world’s second leading infectious disease killer after COVID-19. Drug resistance to TB is a public health crisis. ISB researchers have developed algorithms to predict the efficacy of drugs in treating Mycobacterium tuberculosis (MTB), the causative agent for TB. These research findings were published in the journal Cell Reports Methods. 

ISB Creates Algorithms To Accelerate Discovery of Efficacious Treatments for Tuberculosis
ISB Creates Algorithms To Accelerate Discovery of Efficacious Treatments for Tuberculosis
1 2 3 4 5